Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
Agios Pharmaceuticals, Inc. will present at the Leerink Partners Global Biopharma Conference on March 12, 2024, showcasing their innovative therapies for rare diseases. The presentation will be available via live webcast and archived for two weeks on their website.
03/05/2024 - 07:00 AM
CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the Leerink Partners Global Biopharma Conference on Tuesday, March 12, 2024, at 10:00 a.m. ET.
A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com . A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation.
About Agios www.agios.com
Contacts:
Investor Contact IR@agios.com
Media Contact dan@1abmedia.com
When is Agios Pharmaceuticals, Inc. presenting at the Leerink Partners Global Biopharma Conference?
Agios Pharmaceuticals, Inc. is scheduled to present at the Leerink Partners Global Biopharma Conference on Tuesday, March 12, 2024, at 10:00 a.m. ET.
Where can I access the live webcast of Agios Pharmaceuticals, Inc.'s presentation?
The live webcast of Agios Pharmaceuticals, Inc.'s presentation can be accessed under 'Events & Presentations' in the Investors section of the company's website at www.agios.com.
How long will the replay of Agios Pharmaceuticals, Inc.'s webcast be available?
A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation.
Agios Pharmaceuticals Inc
AGIO Rankings
#3738 Ranked by Stock Gains
AGIO Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Cambridge
About AGIO
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
